Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GPCR
#1611
Structure Therapeutics Inc - American Depositary Shares
47.8
1
USD
+0.04%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+4.14%
Monthly Change
-0.40%
6 month change
-22.89%
Year Change
+78.80%
Previous Close
45.9
1
Open
47.5
6
Low
47.2
2
High
47.8
7
Volume
140
Markets
US Stock Market
Healthcare
Biotechnology
GPCR
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Q2, 26
Current
Key stats
Total common shares outstanding
57.54 M
57.6 M
60.68 M
70.84 M
71.07 M
71.31 M
71.31 M
Valuation ratios
Enterprise value
843.84 M
1.05 B
1.6 B
4.13 B
3.11 B
3.55 B
3.25 B
Price to earnings ratio
-19.9
-19.75
-22.95
-86.94
-54.77
-53.14
-48.87
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
20.45
21.17
24.45
-55.59
-53.57
-47.31
-43.51
Price to book ratio
0.77
1.01
1.46
8.15
2
2.08
1.91
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.05
-0.08
-0.08
0.02
-0.05
-0.07
-0.07
Return on equity %
-0.06
-0.08
-0.09
0.02
-0.05
-0.08
-0.08
Return on invested capital %
-747.73
-753.42
-746.1
131.56
-456.41
-647.49
-647.49
Gross margin %
—
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
23.29
20.48
14.15
24.81
26.16
20.75
20.75
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.3
-0.32
-0.29
-0.36
0.07
-0.55
-1.13
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
4.86
4.56
4.55
8.14
6.71
6.16
6.16
Net current asset value per share
4.94
4.64
4.64
8.84
6.86
6.29
6.29
Tangible book value per share
4.79
4.48
4.39
8.54
6.66
6.21
6.21
Working capital per share
4.73
4.41
4.31
8.49
6.6
5.99
5.99
Book value per share
4.79
4.48
4.39
8.54
6.66
6.21
6.21
News
Can CagriSema Help Novo Nordisk Close the Gap With LLY in Obesity?
Septerna: GPCR Programs May Be Experimental, But I'm Holding For The Long Term (SEPN)
NVO vs. GPCR: Which Obesity Stock Is the Better Buy Right Now?
Structure Therapeutics - A Strong Bet For An Oral GLP-1 Approval Before 2030 (NASDAQ:GPCR)
Can Awiqli Help Novo Nordisk Build a New Growth Engine Beyond GLP-1s?
How Does LLY's Q2 GLP-1 Portfolio Performance Stack Up Against NVO's?
LLY Up Around 6% Post Robust Q2 Results: Buy, Sell or Hold the Stock?
Can Novo Nordisk's GLP-1 Pill Momentum Offset LLY's Growing Edge?
LLY's Foundayo Posts $98M in Q2 Sales: What's Next for the Oral GLP-1?
Novo Nordisk Dips 4% in a Month: How Should Investors Play the Stock?
The BioRevolution Has Accelerated
Novo Nordisk Before Q2 Earnings: How Should Investors Play the Stock?